FDA Inspection 1086589 — Biofermin Pharmaceutical Co., Ltd. Kobe Plant
The FDA completed an inspection of Biofermin Pharmaceutical Co., Ltd. Kobe Plant on Jan 25, 2019 in Kobe. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2019
- Fiscal Year
- 2019
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Kobe (Japan)